G. Papanicolaou

发表

Determinants of COVID-19 disease severity in patients with cancer

E. Robilotti, N. E. Babady, P. Mead, 2020, Nature Medicine.

Discrimination of extended-spectrum beta-lactamases by a novel nitrocefin competition assay

G. Papanicolaou, A. Medeiros, G. Papanicolaou, 1990, Antimicrobial Agents and Chemotherapy.

Screening and Prevention of Hepatitis B Virus Reactivation During Chemotherapy.

G. Papanicolaou, S. Seo, E. Ludwig, 2015, Oncology.

Echinacea purpurea (L.) Moench modulates human T-cell cytokine response.

G. Papanicolaou, E. Kennelly, C. Lau, 2014, International immunopharmacology.

Echinocandin prophylaxis in patients undergoing haematopoietic cell transplantation and other treatments for haematological malignancies

G. Papanicolaou, S. Seo, David J. Epstein, 2018, The Journal of antimicrobial chemotherapy.

Infections in Patients with Hematologic Malignancies

G. Papanicolaou, J. Mehta, 2011 .

BK polyoma virus nephropathy in hematopoietic cell transplant recipients

Yeon Joo Lee, G. Papanicolaou, E. Jaimes, 2019, Journal of Onco-Nephrology.

TLR1 and TLR6 Polymorphisms Are Associated with Susceptibility to Invasive Aspergillosis after Allogeneic Stem Cell Transplantation

J. Satagopan, G. Papanicolaou, P. Peterlongo, 2005, Annals of the New York Academy of Sciences.

Disseminated Adenovirus Infection in Cancer Patients Presenting with Focal Pulmonary Consolidation

N. E. Babady, Yeon Joo Lee, G. Papanicolaou, 2013, Journal of Clinical Microbiology.

Disseminated Mycobacterium marinum infection in a hematopoietic stem cell transplant recipient

A. Kaltsas, G. Papanicolaou, M. Lacouture, 2012, Transplant infectious disease : an official journal of the Transplantation Society.

Clinical and Pharmacological Considerations for Concomitant Administration of Posaconazole and Isavuconazole with Letermovir

G. Papanicolaou, J. Terrier, C. van Delden, 2021, Antimicrobial Agents and Chemotherapy.

Invasive Non-Aspergillus Mold Infections in Transplant Recipients, United States, 2001–2006

G. Papanicolaou, E. Anaissie, G. Lyon, 2011, Emerging infectious diseases.

Brincidofovir for polyomavirus-associated nephropathy after allogeneic hematopoietic stem cell transplantation.

Yeon Joo Lee, G. Papanicolaou, James W. Young, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Determinants of Severity in Cancer Patients with COVID-19 Illness

E. Robilotti, N. E. Babady, P. Mead, 2020, medRxiv.

Robust Vaccine Responses in Adult and Pediatric Cord Blood Transplantation Recipients Treated for Hematologic Malignancies.

G. Papanicolaou, M. Perales, S. Devlin, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Mycobacterium haemophilum Infection after Alemtuzumab Treatment

M. Glickman, G. Papanicolaou, K. Sepkowitz, 2008, Emerging infectious diseases.

Tuberculosis in orthotopic liver transplant patients: increased toxicity of recommended agents; cure of disseminated infection with nonconventional regimens.

G. Papanicolaou, B. Meyers, S. Emre, 2000, Transplantation.

Relationship of BK polyoma virus (BKV) in the urine with hemorrhagic cystitis and renal function in recipients of T Cell-depleted peripheral blood and cord blood stem cell transplantations.

Yeon Joo Lee, G. Papanicolaou, T. Son, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Paradoxical immune reconstitution inflammatory syndrome associated with disseminated tuberculosis infection in an unrelated donor cord blood transplant recipient

Yeon Joo Lee, G. Papanicolaou, E. Schmidt, 2018, Transplant infectious disease : an official journal of the Transplantation Society.

Outcomes of refractory cytomegalovirus (CMV) infection in the first year after allogeneic hematopoietic cell transplantation.

G. Papanicolaou, M. Perales, R. Tamari, 2022, Transplantation and cellular therapy.

Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid-organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study

G. Papanicolaou, M. Boeckh, F. Marty, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Revised Guidelines for Coronavirus Disease 19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients (August 2022)

G. Papanicolaou, S. Seo, M. Kamboj, 2022, Transplantation and Cellular Therapy.

A Positive Prospective Trial of Antibiotic Therapy in Advanced Stage, Non-Bulky Indolent Lymphoma.

G. Papanicolaou, H. Schoder, A. Markowitz, 2015, Tumor microenvironment and therapy.

Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality.

G. Papanicolaou, B. Meyers, S. Emre, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Toll-like receptor 4 polymorphisms and risk of gram-negative bacteremia after allogeneic stem cell transplantation. A prospective pilot study.

J. Satagopan, G. Papanicolaou, P. Peterlongo, 2009, Biology of Blood and Marrow Transplantation.

Risk factors for late Staphylococcus aureus bacteremia after allogeneic hematopoietic stem cell transplantation: a single-institution, nested case-controlled study.

G. Papanicolaou, K. Sepkowitz, E. Pamer, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

False-Positive Results for Human Immunodeficiency Virus Type 1 Nucleic Acid Amplification Testing in Chimeric Antigen Receptor T Cell Therapy

N. E. Babady, G. Papanicolaou, Yi-Wei Tang, 2019, Journal of Clinical Microbiology.

Clostridium difficile infection after allogeneic hematopoietic stem cell transplant: strain diversity and outcomes associated with NAP1/027.

A. Kaltsas, G. Papanicolaou, K. Sepkowitz, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Trends in Invasive Pneumococcal Disease in Cancer Patients After the Introduction of 7-valent Pneumococcal Conjugate Vaccine: A 20-year Longitudinal Study at a Major Urban Cancer Center

A. Kaltsas, Yeon Joo Lee, G. Papanicolaou, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Sequential systematic anti‐mold prophylaxis with micafungin and voriconazole results in very low incidence of invasive mold infections in patients undergoing allogeneic hematopoietic stem cell transplantation

G. Papanicolaou, M. Perales, S. Devlin, 2018, Transplant infectious disease : an official journal of the Transplantation Society.

Secondary antibody deficiency in chronic lymphocytic leukemia and non-Hodgkin lymphoma: Recommendations from an international expert panel

G. Papanicolaou, J. Wingard, D. Vinh, 2022, Blood Reviews.

Editorial: Friends and foes: "The quarrels of friends are the opportunities of foes".

G. Papanicolaou, D. Neofytos, 2022, Current opinion in infectious diseases.

Echinacea purpurea aerial extract alters course of influenza infection in mice.

G. Papanicolaou, Y. Taur, E. Kennelly, 2010, Vaccine.

Safety and efficacy of intravenously administered cidofovir in adult haematopoietic cell transplant recipients: a retrospective multicentre cohort study.

G. Papanicolaou, C. Scheid, R. Avery, 2021, The Journal of antimicrobial chemotherapy.

Hepatic safety of voriconazole after allogeneic hematopoietic stem cell transplantation.

G. Papanicolaou, S. Seo, N. Cohen, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pneumocystis carinii Pneumonia prophylaxis with atovaquone in trimethoprim‐sulfamethoxazole–intolerant orthotopic liver transplant patients: A preliminary study

G. Papanicolaou, B. Meyers, F. Borrego, 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer

N. E. Babady, G. Papanicolaou, K. Sepkowitz, 2020, The New England journal of medicine.

Impact of Preemptive Therapy for Cytomegalovirus on Toxicities after Allogeneic Hematopoietic Cell Transplantation in Clinical Practice. A Retrospective Single Center Cohort Study.

G. Papanicolaou, M. Perales, S. Giralt, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation

G. Papanicolaou, M. Boeckh, F. Marty, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cutaneous involvement of disseminated adenovirus infection in an allogeneic stem cell transplant recipient

M. Marchetti, G. Papanicolaou, K. Busam, 2016, The British journal of dermatology.

CMV viral load kinetics predict CMV end-organ disease and mortality after hematopoietic cell transplant (HCT).

G. Papanicolaou, M. Perales, S. Giralt, 2021, The Journal of infectious diseases.

Adenovirus viral kinetics and mortality in ex-vivo T-cell depleted hematopoietic cell transplant recipients with adenovirus infection from a single center.

Yeon Joo Lee, G. Papanicolaou, M. Perales, 2020, The Journal of infectious diseases.

Infectious ocular complications in orthotopic liver transplant patients.

G. Papanicolaou, B. Meyers, S. Emre, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Hematologic safety profile of linezolid in the early periengraftment period after allogeneic stem cell transplantation.

G. Papanicolaou, S. Seo, G. Heller, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Frequently Asked Questions on Coronavirus Disease 2019 Vaccination for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Recipients From the American Society for Transplantation and Cellular Therapy and the American Society of Hematology

G. Papanicolaou, M. Kamboj, J. Wingard, 2022, Transplantation and Cellular Therapy.

Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients.

G. Papanicolaou, J. Kurtzberg, S. Way, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Patients following Allogeneic Hematopoietic Stem Cell Transplantation in the United States.

G. Papanicolaou, J. McGuirk, A. Chandak, 2021, Transplantation and cellular therapy.

Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation.

N. E. Babady, Yeon Joo Lee, G. Papanicolaou, 2020, The Journal of clinical investigation.

Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae

G. Papanicolaou, G. Jacoby, A. Medeiros, 1990, Antimicrobial Agents and Chemotherapy.

Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease.

G. Papanicolaou, J. Wagner, S. Yanovich, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Brincidofovir for Prevention of Cytomegalovirus (CMV) after Allogeneic Hematopoietic Cell Transplantation (HCT) in CMV-Seropositive Patients: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 3 Trial

G. Papanicolaou, M. Boeckh, F. Marty, 2016 .

Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.

Thomas J Walsh, Randall Walker, Kieren A Marr, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Safety and Efficacy of Intermittent Intravenous Administration of High-Dose Micafungin.

G. Papanicolaou, M. Perales, N. Cohen, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impacts and Challenges of Advanced Diagnostic Assays for Transplant Infectious Diseases

N. E. Babady, Yeon Joo Lee, G. Papanicolaou, 2018, Principles and Practice of Transplant Infectious Diseases.

A single center, open-label trial of isavuconazole prophylaxis against invasive fungal infection in patients undergoing allogeneic hematopoietic cell transplant (HCT).

Yeon Joo Lee, G. Papanicolaou, S. Seo, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study.

R. Vij, G. Papanicolaou, M. Boeckh, 2008, Blood.

Efficacy and safety of isavuconazole compared with voriconazole as primary antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients.

Yeon Joo Lee, G. Papanicolaou, S. Seo, 2021, Medical mycology.

Real-World Experience of Voriconazole Prophylaxis in Allogeneic Hematopoietic Cell Transplant Recipients: A Single-Center Study

G. Papanicolaou, M. Perales, D. Neofytos, 2017, Open Forum Infectious Diseases.

Guidelines for COVID-19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients

G. Papanicolaou, M. Kamboj, M. Boeckh, 2020, Biology of Blood and Marrow Transplantation.

CMV Prevention and Treatment in Transplantation: What’s New in 2019

G. Papanicolaou, A. Stern, 2019, Current Infectious Disease Reports.

Impact of peri-transplant vancomycin and fluoroquinolone administration on rates of bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients: a 12-year single institution study.

G. Papanicolaou, S. Seo, S. Giralt, 2014, The Journal of infection.

Concurrent pulmonary Aspergillus and non-Aspergillus mold infections in allogeneic hematopoetic cell transplant recipients.

A. Kaltsas, Yeon Joo Lee, G. Papanicolaou, 2022, Transplant immunology.

Reasons for voriconazole prophylaxis discontinuation in allogeneic hematopoietic cell transplant recipients: A real-life paradigm.

G. Papanicolaou, M. Perales, D. Neofytos, 2020, Medical mycology.

Micafungin versus posaconazole prophylaxis in acute leukemia or myelodysplastic syndrome: A randomized study.

G. Papanicolaou, S. Seo, M. Tallman, 2018, The Journal of infection.

Serious infection risk and immune recovery after double-unit cord blood transplantation without antithymocyte globulin.

G. Papanicolaou, M. Perales, M. V. D. van den Brink, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

BACTERIAL BLOOD STREAM INFECTIONS (BSI), PARTICULARLY POST-ENGRAFTMENT BSI, ARE ASSOCIATED WITH INCREASED MORTALITY AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

G. Papanicolaou, V. Brown, M. Aljurf, 2018, Bone Marrow Transplantation.

Safety and Efficacy of Intermittent Intravenous Administration of High-Dose Micafungin.

G. Papanicolaou, M. Perales, N. Cohen, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

American Society for Transplantation and Cellular Therapy Series: #6 - Management of Invasive Candidiasis in Hematopoietic Cell Transplant Recipients.

G. Papanicolaou, K. Hanson, W. Steinbach, 2023, Transplantation and cellular therapy.

Oral Brincidofovir Decreased the Incidence of HHV-6B Viremia after Allogeneic HCT.

G. Papanicolaou, M. Boeckh, F. Marty, 2020, Blood.

Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies.

G. Papanicolaou, R. Rubin, M. Boeckh, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

American Society for Transplantation and Cellular Therapy Series: #3-Prevention of Cytomegalovirus Infection and Disease After Hematopoietic Cell Transplantation.

G. Papanicolaou, M. Boeckh, F. Marty, 2021, Transplantation and cellular therapy.

Predictors for persistent cytomegalovirus reactivation after T‐cell‐depleted allogeneic hematopoietic stem cell transplantation

G. Papanicolaou, K. Sepkowitz, E. Pamer, 2007, Transplant infectious disease : an official journal of the Transplantation Society.

The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients.

G. Papanicolaou, S. Seo, K. Sepkowitz, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

American Society of Transplantation and Cellular Therapy Series: #4 - Cytomegalovirus treatment and management of resistant or refractory infections after hematopoietic cell transplantation.

G. Papanicolaou, Yae-Jean Kim, R. Chemaly, 2021, Transplantation and cellular therapy.

Extended-duration letermovir prophylaxis for cytomegalovirus infection after cord blood transplantation in adults

G. Papanicolaou, S. Seo, M. Perales, 2022, Blood advances.

Incidence, nature and mortality of cytomegalovirus infection after double-unit cord blood transplant

G. Papanicolaou, M. Perales, S. Devlin, 2015, Leukemia & lymphoma.

Valganciclovir for the Prevention of Complications of Late Cytomegalovirus Infection After Allogeneic Hematopoietic Cell Transplantation

G. Papanicolaou, W. Leisenring, T. Stevens-Ayers, 2015, Annals of Internal Medicine.

Monitoring of Cytomegalovirus Viral Loads by Two Molecular Assays in Whole-Blood and Plasma Samples from Hematopoietic Stem Cell Transplant Recipients

N. E. Babady, G. Papanicolaou, Yi-Wei Tang, 2015, Journal of Clinical Microbiology.

Difficult Balance Between Multidrug-Resistant Cytomegalovirus Infection and Graft-Versus-Host Disease in an Allogeneic Hematopoietic Stem Cell Transplant Recipient

G. Papanicolaou, N. Lurain, Y. Rhee, 2020 .

CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation.

G. Papanicolaou, M. Boeckh, F. Marty, 2013, The New England journal of medicine.

Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin.

G. Papanicolaou, M. Perales, S. Devlin, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Therapy.

G. Papanicolaou, M. Kamboj, M. Perales, 2021, Blood cancer discovery.

Disease- and Therapy-Specific Impact on Humoral Immune Responses to COVID-19 Vaccination in Hematologic Malignancies.

G. Papanicolaou, M. Kamboj, S. Devlin, 2021, Blood cancer discovery.

A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients.

G. Papanicolaou, K. Sullivan, T. Shea, 2014, Blood.

Ability of ceftibuten to induce the class-I beta-lactamases of Enterobacter cloacae, Serratia marcescens, and Enterobacter aerogenes.

G. Papanicolaou, A. Medeiros, 1991, Diagnostic microbiology and infectious disease.

Detection of human norovirus in intestinal biopsies from immunocompromised transplant patients.

N. Ajami, G. Papanicolaou, M. Perales, 2016, The Journal of general virology.

Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial.

H. Einsele, G. Papanicolaou, M. Boeckh, 2011, The Lancet. Infectious diseases.

Efficacy of brincidofovir as prophylaxis against HSV and VZV in hematopoietic cell transplant recipients

Leslie A. Cheteyan, Yeon Joo Lee, G. Papanicolaou, 2018, Transplant infectious disease : an official journal of the Transplantation Society.

Impact of preemptive therapy for Cytomegalovirus on hospitalizations and cost after Hematopoietic Stem Cell Transplantation.

G. Papanicolaou, M. Perales, S. Giralt, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cytomegalovirus resistance in CD34+‐selected hematopoietic cell transplant recipients

Yeon Joo Lee, G. Papanicolaou, J. Foldi, 2018, Transplant infectious disease : an official journal of the Transplantation Society.

Approach to adenovirus infections in the setting of hematopoietic cell transplantation

Yeon Joo Lee, G. Papanicolaou, S. Prockop, 2017, Current opinion in infectious diseases.

Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility

G. Papanicolaou, L. Rice, G. Eliopoulos, 1990, Antimicrobial Agents and Chemotherapy.

Infectious disease associations in advanced stage, indolent lymphoma (follicular and nonfollicular): developing a lymphoma prevention strategy.

W. Chey, G. Papanicolaou, I. Schwartz, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Determinants of COVID-19 disease severity in patients with cancer

E. Robilotti, N. E. Babady, P. Mead, 2020, Nature Medicine.

Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real‐world experience

G. Papanicolaou, S. Seo, M. Perales, 2019, Transplant infectious disease : an official journal of the Transplantation Society.

Lack of a significant pharmacokinetic interaction between letermovir and calcineurin inhibitors in allogeneic HCT recipients

G. Papanicolaou, S. Seo, M. Perales, 2019, Bone Marrow Transplantation.

Bacterial bloodstream infections in the allogeneic hematopoietic cell transplant patient: new considerations for a persistent nemesis

M. Ardura, G. Papanicolaou, C. Dandoy, 2017, Bone Marrow Transplantation.

Hematopoietic Cell Transplantation is Feasible in Patients with Prior COVID-19 Infection

G. Papanicolaou, M. Kamboj, M. Perales, 2021, Transplantation and Cellular Therapy.

Human herpes virus 6 DNAemia is associated with worse survival after ex vivo T-cell depleted hematopoietic cell transplant.

Yeon Joo Lee, G. Papanicolaou, M. Perales, 2021, The Journal of infectious diseases.

Cytomegalovirus Infection in Allogeneic Hematopoietic Cell Transplantation Managed by the Preemptive Approach: Estimating the Impact on Healthcare Resource Utilization and Outcomes.

G. Papanicolaou, M. Perales, S. Giralt, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Letermovir Prophylaxis Demonstrates High Efficacy in Adult Cytomegalovirus (CMV) Seropositive Cord Blood Transplant (CBT) Recipients: A Comparison with Pre-Letermovir Era CBT Controls

G. Papanicolaou, S. Seo, M. Perales, 2019, Biology of Blood and Marrow Transplantation.

T cell-depleted unrelated donor stem cell transplantation provides favorable disease-free survival for adults with hematologic malignancies.

G. Papanicolaou, M. Perales, M. V. D. van den Brink, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Co-Infections by Double-Stranded DNA Viruses after Ex Vivo T Cell-Depleted, CD34+ Selected Hematopoietic Cell Transplantation.

Yeon Joo Lee, G. Papanicolaou, M. Perales, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Frequently Asked Questions about Mpox (Formerly Monkeypox Disease) for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Recipients from the American Society for Transplantation and Cellular Therapy

G. Papanicolaou, S. Pergam, E. Ford, 2023, Transplantation and cellular therapy.

Cytomegalovirus Infection after CD34(+)-Selected Hematopoietic Cell Transplantation.

G. Papanicolaou, M. Perales, J. Foldi, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor-CD4 + T-cells: A Trojan horse for Human herpes virus 6 after Allogeneic Hematopoietic Cell Transplantation?

Yeon Joo Lee, G. Papanicolaou, Yiqi Su, 2021, The Journal of infectious diseases.

Acetobacter tropicalis bacteraemia in an immunocompromised patient: case report

N. E. Babady, G. Papanicolaou, Kevin M. Raible, 2022, Access microbiology.

Time to initiation of pre-emptive therapy for cytomegalovirus impacts overall survival in pediatric hematopoietic stem cell transplant recipients

G. Papanicolaou, A. Mauguen, S. Prockop, 2022, Cytotherapy.

Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial

G. Papanicolaou, J. Mehta, J. Panse, 2018, The Lancet.

Treatment of Adenovirus (AdV) Infection in Allogeneic Hematopoietic Cell Transplant (allo HCT) Patients (pts) with Brincidofovir: Final 36 Week Results from the Advise Trial

G. Papanicolaou, T. Brundage, V. Prasad, 2017 .

Transmission of Clostridium difficile During Hospitalization for Allogeneic Stem Cell Transplant

E. Robilotti, G. Papanicolaou, K. Sepkowitz, 2015, Infection Control & Hospital Epidemiology.

Implementation of Molecular Surveillance After a Cluster of Fatal Toxoplasmosis at 2 Neighboring Transplant Centers.

N. E. Babady, G. Papanicolaou, K. Sepkowitz, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Kitten-transmitted Bordetella bronchiseptica infection in a patient receiving temozolomide for glioblastoma

G. Papanicolaou, G. Redelman-Sidi, C. Grommes, 2011, Journal of Neuro-Oncology.

CMX001 for Prevention and Control of CMV Infection in CMV-Seropositive Allogeneic Stem-Cell Transplant Recipients: A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Trial of Safety, Tolerability and Antiviral Activity

G. Papanicolaou, M. Boeckh, F. Marty, 2012 .

A Phase I Dose Escalation Trial of Donor T Cells Sensitized with Pentadecapeptides of the CMV-pp65 Protein for the Treatment of CMV Infections Following Allogeneic Hematopoietic Stem Cell Transplants.

G. Papanicolaou, M. Perales, James W. Young, 2009 .

Rapid expansion of cytomegalovirus-specific cytotoxic T lymphocytes by artificial antigen-presenting cells expressing a single HLA allele.

G. Papanicolaou, E. Pamer, M. Sadelain, 2003, Blood.

Prophylaxis Against Cytomegalovirus Infections with Oral Maribavir in Allogeneic Stem Cell Transplant Recipients: Results of a Randomized, Double-Blind, Placebo-Controlled Trial.

R. Vij, G. Papanicolaou, M. Boeckh, 2006 .

Challenges of Cytomegalovirus (CMV) Management after CD34+ Selected, T-Cell Depleted (TCD) Hematopoietic Cell Transplantation (HCT): A Five-Year Experience at Memorial Sloan Kettering

Yeon Joo Lee, G. Papanicolaou, M. Perales, 2016 .

Cytomegalovirus Viremia and Death After Hematopoietic Cell Transplantation: More Complex Than “To Have and Have Not”?

G. Papanicolaou, M. Perales, 2019, Clinical Infectious Diseases.

Practice patterns and incidence of adenovirus infection in allogeneic hematopoietic cell transplant recipients: Multicenter survey of transplant centers in the United States

G. Papanicolaou, R. Giller, A. Chandak, 2020, Transplant infectious disease : an official journal of the Transplantation Society.

Adenovirus viremia and disease: comparison of T cell-depleted and conventional hematopoietic stem cell transplantation recipients from a single institution.

Yeon Joo Lee, G. Papanicolaou, Junting Zheng, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Increased overall and bacterial infections following myeloablative allogeneic HCT for patients with AML in CR1.

G. Papanicolaou, V. Brown, M. Perales, 2019, Blood advances.

ASH-ASTCT: SARS-CoV-2 Vaccines in Immunocompromised Patients FAQs (V3 Posted 6/14/2021)

Alpana, G. Papanicolaou, T. Hohl, 2021 .

Bloodstream infection (BSI) due to Vancomycin-Resistant Enterococcus (VRE) is associated with increased mortality after hematopoietic cell transplantation for acute leukemia and myelodysplastic syndrome: A multicenter, retrospective cohort study.

G. Papanicolaou, K. Komanduri, K. Ahn, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Prevention of peritransplantation viridans streptococcal bacteremia with early vancomycin administration: a single-center observational cohort study.

G. Papanicolaou, K. Sepkowitz, E. Pamer, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of Empiric Treatment for Vancomycin-Resistant Enterococcus in Colonized Patients Early after Allogeneic Hematopoietic Stem Cell Transplantation.

G. Papanicolaou, S. Seo, K. Sepkowitz, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Transplant infectious disease landscape in the COVID19-Era.

G. Papanicolaou, D. Neofytos, 2021, Current opinion in infectious diseases.

Diagnosis of Extrapulmonary Legionellosis in Allogeneic Hematopoietic Cell Transplant Recipients by Direct 16S Ribosomal Ribonucleic Acid Sequencing and Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry

M. Rosenblum, Yeon Joo Lee, G. Papanicolaou, 2017, Open forum infectious diseases.

Effect of Linezolid on Clinical Severity and Pulmonary Cytokines in a Murine Model of Influenza A and Staphylococcus aureus Coinfection

G. Papanicolaou, Julie R. White, X. Liu, 2013, PloS one.

Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial

G. Papanicolaou, B. Alexander, Deepali Kumar, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Recommendations for Management of Secondary Antibody Deficiency in Multiple Myeloma.

G. Papanicolaou, J. Wingard, D. Vinh, 2023, Clinical lymphoma, myeloma & leukemia.

Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant

G. Papanicolaou, M. Perales, Jinjuan Yao, 2023, The Journal of Clinical Investigation.

Severe influenza and S. aureus pneumonia

G. Papanicolaou, 2013, Virulence.

American Society for Transplantation and Cellular Therapy Infectious Disease Guidelines: Preface to the Series.

G. Papanicolaou, M. Boeckh, R. Chemaly, 2021, Transplantation and cellular therapy.

452Pseudo-Outbreak of Fulminant Toxoplasmosis in Hematopoietic Stem Cell Transplant [HSCT] Recipients

G. Papanicolaou, M. Kamboj, K. van Besien, 2014, Open Forum Infectious Diseases.

544. PICKUP: Pneumonia in the Immunocompromised - Use of the Karius Test for Detection of Undiagnosed Pathogens

T. Blauwkamp, Yeon Joo Lee, G. Papanicolaou, 2022, Open Forum Infectious Diseases.

Atypical pathogens presenting with pulmonary consolidations detected by cell-free DNA next-generation sequencing in patients with hematologic malignancies.

W. Travis, Yeon Joo Lee, A. Mariano, 2022, Infectious diseases in clinical practice.

Retrospective study of the hepatic safety profile of patients concomitantly treated with caspofungin and cyclosporin A

G. Papanicolaou, J. Chodakewitz, K. Marr, 2004, Transplant infectious disease : an official journal of the Transplantation Society.

Pre‐ and post‐engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients

G. Papanicolaou, K. Sepkowitz, E. Pamer, 2005, Transplant infectious disease : an official journal of the Transplantation Society.

How I Prevent Viral Reactivation in High-risk Patients.

G. Papanicolaou, S. Dadwal, M. Boeckh, 2022, Blood.

Toxoplasma Encephalitis in Atypical Hosts at an Academic Cancer Center

M. Rosenblum, A. Kaltsas, S. Morjaria, 2016, Open forum infectious diseases.

Humoral immune Responses to cOViD-19 Vaccination in Hematologic Malignancies

G. Papanicolaou, M. Kamboj, S. Devlin, 2021 .

The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients.

G. Papanicolaou, S. Seo, K. Sepkowitz, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Revised Guidelines for Coronavirus Disease 19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients (August 2022) IN PRESS Transplantation and Cellular Therapy

G. Papanicolaou, M. Kamboj, M. Boeckh, 2022 .

Revised Guidelines for Coronavirus Disease 19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients (August 2022)

G. Papanicolaou, M. Kamboj, M. Boeckh, 2022 .

Revised Guidelines for Coronavirus Disease 19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients (August 2022) IN PRESS Transplantation and Cellular Therapy

G. Papanicolaou, M. Kamboj, M. Boeckh, 2022 .

Revised Guidelines for Coronavirus Disease 19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients (August 2022)

G. Papanicolaou, M. Kamboj, M. Boeckh, 2022 .

Toll-like receptor 4 polymorphisms and risk of gram-negative bacteremia after allogeneic stem cell transplantation. A prospective pilot study.

J. Satagopan, G. Papanicolaou, P. Peterlongo, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation.

G. Papanicolaou, M. Boeckh, F. Marty, 2013, The New England journal of medicine.

Post-transplantation cyclophosphamide is associated with increased bacterial infections.

G. Papanicolaou, M. Perales, C. Dandoy, 2023, Bone marrow transplantation.

Invasive adenoviral infections in T‐cell‐depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir

G. Papanicolaou, K. Sepkowitz, E. Pamer, 2007, Transplant infectious disease : an official journal of the Transplantation Society.

Outcomes and Management of SARS-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation (HCT) and Chimeric Antigen Receptor T cell (CART) therapy.

Yeon Joo Lee, G. Papanicolaou, M. Kamboj, 2023, Transplantation and cellular therapy.